Within the first two years after graduation, resident doctors show prescribing error rates up to twice those of other healthcare professionals. Researchers attribute part of this gap to limited opportunities for deliberate practice and feedback under realistic clinical uncertainty.

During Sense about Science Evidence Week, Taylor & Francis showcased findings highlighting the role of structured, video-enhanced feedback in improving prescribing performance. The core idea is to turn everyday prescribing moments into measurable learning cycles.

In collaboration with Professor Rakesh Patel, Director of Undergraduate Medicine at St Mary’s University, the work draws on evidence published in Medical Teacher. The study evaluates how personalized feedback—paired with short video-based review—can target specific decision points rather than generic coaching.

Importantly, the intervention is designed to close the performance gap between novice and experienced prescribers. That effect is framed as a shift from “knowing what to do” toward reliably demonstrating safe behavior in routine, high-pressure environments.

The program’s feasibility is also emphasized: it is described as cost-effective and scalable across Foundation Training. Scaling matters because training quality often varies, while prescribing risks affect patients at national scale.

Policy implications were a key part of the message delivered at Evidence Week. Speakers argued for accrediting prescribing competence using performance metrics observed in practice, so assessment reflects safe outcomes rather than exam passage alone.

“It is clear that education without structured feedback is not enough,” Patel said, adding that personalized feedback supported by performance data helps newly qualified doctors develop safer prescribing behaviours.

Sense about Science’s Evidence Week—now in its ninth year—brings MPs and scientists together for rapid briefings on policy-relevant research. Organizers say the format helps align government decision-making with real-world evidence.

Subject of Research: Prescribing safety training for newly qualified resident doctors; structured video-enhanced feedback in medical education
Article Title: “published in the journal Medical Teacher” (exact title not provided in the provided content)
News Publication Date: Not provided in the provided content
Web References: https://senseaboutscience.org/evidence-week/ ; https://www.tandfonline.com/doi/full/10.1080/0142159X.2020.1748183
References: Taylor & Francis / Medical Teacher article linked above (exact citation details not provided in the provided content)
Image Credits: Not provided in the provided content
Keywords: prescribing errors, medical education reform, video-enhanced feedback, foundation training, patient safety, performance metrics, resident doctors, clinical decision-making

The M-IMSIS was conceived out of the pressing need to engage patients in their own medication safety. Research indicates that active participation can dramatically reduce medication errors, which are a leading cause of adverse drug events. Understanding this connection, the authors embarked on a journey to create an instrument that accurately measures patient involvement, tailored specifically for the Malay-speaking population. Through meticulous development processes, they ensured the scale aligns with local cultural nuances, thus promoting better understanding and usability among patients.

Translation of psychological and health-related assessment tools can be fraught with difficulties. It requires more than mere linguistic conversion; researchers must also ensure that cultural relevancy and context are preserved. The authors employed both forward and backward translation methods, a rigorous approach that helps maintain the integrity of the original meaning while adapting it for local relevance. This careful consideration of cultural context is essential in ensuring that the M-IMSIS resonates with patients, ultimately leading to more effective communication about medication safety.

Once the scale was translated, the validation process commenced. The study involved a diverse group of participants from various backgrounds, underscoring the importance of inclusivity in research. The researchers utilized a combination of qualitative and quantitative methods to assess the scale’s reliability and validity. By gathering feedback from patients and healthcare professionals, they identified any potential gaps in the instrument’s effectiveness, constantly refining the scale based on empirical evidence.

The validation process highlighted key components that might influence a patient’s involvement in medication safety. For instance, factors such as health literacy, previous experiences with medications, and even the therapeutic alliance between healthcare providers and patients were examined. Through this comprehensive approach, it became evident that the M-IMSIS could serve as a fundamental resource in not just identifying risks, but in also creating strategies to enhance patient education and engagement.

Another significant aspect addressed in the study is the implications of using the M-IMSIS within clinical practice. By integrating this scale into daily hospital routines, healthcare professionals can better gauge the level of patient involvement in medication safety. This feedback is invaluable, as it not only empowers patients but also allows healthcare providers to tailor their education efforts, ensuring that patients understand the medications prescribed to them and their associated risks.

Furthermore, the M-IMSIS serves as a stepping stone towards broader institutional changes. As hospitals strive to enhance patient safety protocols, having a reliable measure like M-IMSIS can facilitate policy development and implementation. This scale can guide healthcare administrators in assessing current practices, identifying areas for improvement, and fostering a culture of safety within healthcare environments.

The study also sheds light on the potential for adaptation of the M-IMSIS beyond the Malaysian context. As medication practices and patient safety concerns are universal, the framework established for the M-IMSIS could serve as a model for developing similar scales in different cultural contexts. This adaptability presents an exciting opportunity for global healthcare, as it emphasizes the importance of localizing healthcare tools while acknowledging shared challenges around medication safety.

The findings from Nawawi et al. are particularly relevant in today’s landscape, where the healthcare system is under immense pressure to enhance patient outcomes while managing resources effectively. The M-IMSIS represents a practical solution to bridge the gap between patients and healthcare providers, ensuring that both parties are engaged in the medication management process. Such initiatives are crucial as they not only empower patients but also help build trust, contributing to a more robust healthcare system.

In essence, the study by Nawawi and colleagues calls attention to the need for and potential benefits of patient engagement in medication safety. By validating the M-IMSIS, they have laid the groundwork for future research and implementation efforts that can lead to safer healthcare environments. This initiative highlights the ongoing evolution of healthcare practices aimed at prioritizing patient safety and involvement, marking an important chapter in the quest for improved health outcomes.

Ultimately, the work surrounding the M-IMSIS underscores a broader narrative within healthcare – the growing recognition of patients as active collaborators in their own care. The empowerment of patients through tools like the M-IMSIS showcases a shift towards a more participatory approach in healthcare, where patient voices are valued and instrumental in shaping practices that prioritize safety and effectiveness.

As we move forward, lessons learned from this research can serve as a beacon for future studies involving patient engagement and medication safety. The call to action from this study extends beyond the walls of hospitals; it invites stakeholders across the healthcare spectrum to collaborate, innovate, and inspire change. By prioritizing patient involvement and vigilant practices, we can aspire to cultivate a safer, more effective healthcare system that truly serves the needs of all patients.

Advancements in healthcare are often marked by the evolution of tools and practices that prioritize safety and collaboration. The validation of the Malay Inpatient Medication-Safety Involvement Scale represents a crucial milestone in this journey, illuminating the path towards a proactive approach to medication safety and emphasizing the importance of engaging patients as informed partners in their care.

Subject of Research: Empowering patient involvement in medication safety.

Article Title: Empowering safe medication practices: translation and validation of the Malay inpatient medication-safety involvement scale (M-IMSIS).

Article References: Nawawi, M.H.M., Ibrahim, M.I., Yaacob, N.M. et al. Empowering safe medication practices: translation and validation of the Malay inpatient medication-safety involvement scale (M-IMSIS). BMC Health Serv Res 25, 1608 (2025). https://doi.org/10.1186/s12913-025-13717-2

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12913-025-13717-2

Keywords: Medication safety, patient involvement, healthcare practices, M-IMSIS, validation, cultural adaptation.